| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-05 | NCT07748533 HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04586478 | Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or… | Non-Hodgkin's Lymphoma | Recruiting |
| NCT04684147 | Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute… | Relapsed or Refractory Acute Lymphoblastic Leukemia | Recruiting |
| Phase 1/2 | |||
| NCT05667506 | A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) | B-cell Acute Lymphoblastic Leukemia | Recruiting |
| Phase 1 | |||
| NCT06826430 | Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus… | Autoimmune Thrombocytopenia | Recruiting |
| NCT07748533 | HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. | Autoimmune Hemolytic Anemia (AIHA) | Recruiting |
| NCT07091370 | Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After… | AIHA - Cold Autoimmune Hemolytic Anemia | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06316791 | Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of… | Lupus Erythematosus, Systemic | Recruiting |
| NCT07275736 | A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune… | Neurological Autoimmune Diseases | Recruiting |
| NCT07265206 | A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune… | Neurological Autoimmune Diseases | Not Yet Recruiting |
| Not specified | |||
| NCT06450067 | Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute… | B-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06461351 | Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection | B-cell Tumors | Recruiting |